000286275 001__ 286275
000286275 005__ 20240229155124.0
000286275 0247_ $$2doi$$a10.1007/s10585-022-10196-1
000286275 0247_ $$2pmid$$apmid:36646888
000286275 0247_ $$2pmc$$apmc:PMC9898318
000286275 0247_ $$2ISSN$$a0262-0898
000286275 0247_ $$2ISSN$$a1573-7276
000286275 037__ $$aDKFZ-2023-02762
000286275 041__ $$aEnglish
000286275 082__ $$a610
000286275 1001_ $$00000-0002-9838-9805$$aHenke, Oliver$$b0
000286275 245__ $$aInternational cooperation to fight cancer's late-stage presentation in low- and middle-income countries.
000286275 260__ $$aDordrecht$$bSpringer Science + Business Media B.V.$$c2023
000286275 3367_ $$2DRIVER$$aarticle
000286275 3367_ $$2DataCite$$aOutput Types/Journal article
000286275 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1703158942_2115$$xLetter
000286275 3367_ $$2BibTeX$$aARTICLE
000286275 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000286275 3367_ $$00$$2EndNote$$aJournal Article
000286275 500__ $$a#LA:F210#
000286275 520__ $$aCancer is becoming a massive public health burden in low- and middle-income countries (LMIC). 70% of all cancer deaths globally are attributed to LMIC while the incidence proportion is below 60%. The main reason for the higher mortality rate is 'late-stage presentation' of patients with stage III or IV diseases when being diagnosed. Main reasons for this are limited (financial) resources, poor knowledge of health service provider about cancer, misbelieves and fear among patients as well as low health literacy rate. During the 1st International Conference on Hospital Partnerships, conducted by the German Agency for International Cooperation (GIZ), cancer specialists from seven LMIC and Germany discussed opportunities, challenges and solutions of the development of cancer services. Two days of in-depths discussion identified five topics to be playing a key role in the effort to reduce the cancer burden in LMIC: Health Policy & Financing, Barriers to Access, Capacity Building, Cancer Registries and Adapted Treatment Guidelines. By using mind-mapping technique, stakeholders, core topics, main and important topics were visualized and interconnections displayed. Many topics can be addressed through international cooperations but political willingness and commitment in the respective countries plays the crucial role. An essential contribution will be to assist policy makers in formulating and endorsing affordable and effective health policies. Another lesson learned from this workshop is the similarity of challenges among the participating representatives from different LMIC. The authors of this letter emphasize on the importance of building international long-term cooperations to advance oncology care on a global scale.
000286275 536__ $$0G:(DE-HGF)POF4-316$$a316 - Infektionen, Entzündung und Krebs (POF4-316)$$cPOF4-316$$fPOF IV$$x0
000286275 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000286275 650_7 $$2Other$$aCancer
000286275 650_7 $$2Other$$aCooperation
000286275 650_7 $$2Other$$aGlobal oncology
000286275 650_7 $$2Other$$aLMIC
000286275 650_7 $$2Other$$aMetastasis
000286275 650_2 $$2MeSH$$aHumans
000286275 650_2 $$2MeSH$$aDeveloping Countries
000286275 650_2 $$2MeSH$$aInternational Cooperation
000286275 650_2 $$2MeSH$$aNeoplasms: diagnosis
000286275 650_2 $$2MeSH$$aNeoplasms: therapy
000286275 650_2 $$2MeSH$$aGermany
000286275 7001_ $$aQader, Abdul Qadir$$b1
000286275 7001_ $$aMalle, Goodluck Lincoln$$b2
000286275 7001_ $$aKuiate, Jules Roger$$b3
000286275 7001_ $$aHennig, Lisa$$b4
000286275 7001_ $$aDemeke, Tamiru$$b5
000286275 7001_ $$aStroetmann, Clara$$b6
000286275 7001_ $$aHenke, Antje Anneliese$$b7
000286275 7001_ $$aAlaric, Tamuedjoun Talom$$b8
000286275 7001_ $$aRushanyan, Marine$$b9
000286275 7001_ $$aEnssle, Cornell$$b10
000286275 7001_ $$0P:(DE-He78)c2b16a9737b89d371c1e6bc099412977$$aBussmann, Hermann$$b11$$eLast author$$udkfz
000286275 773__ $$0PERI:(DE-600)1496876-9$$a10.1007/s10585-022-10196-1$$gVol. 40, no. 1, p. 1 - 3$$n1$$p1 - 3$$tClinical & experimental metastasis$$v40$$x0262-0898$$y2023
000286275 909CO $$ooai:inrepo02.dkfz.de:286275$$pVDB
000286275 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c2b16a9737b89d371c1e6bc099412977$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000286275 9131_ $$0G:(DE-HGF)POF4-316$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vInfektionen, Entzündung und Krebs$$x0
000286275 9141_ $$y2023
000286275 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2023-10-21$$wger
000286275 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2023-10-21$$wger
000286275 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2023-10-21$$wger
000286275 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-21
000286275 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-21
000286275 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-21
000286275 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-21
000286275 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-21
000286275 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-21
000286275 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-10-21
000286275 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-21
000286275 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCLIN EXP METASTAS : 2022$$d2023-10-21
000286275 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-21
000286275 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-10-21
000286275 9202_ $$0I:(DE-He78)F210-20160331$$kF210$$lKKE Angewandte Tumorbiologie$$x0
000286275 9201_ $$0I:(DE-He78)F210-20160331$$kF210$$lKKE Angewandte Tumorbiologie$$x0
000286275 980__ $$ajournal
000286275 980__ $$aVDB
000286275 980__ $$aI:(DE-He78)F210-20160331
000286275 980__ $$aUNRESTRICTED